Jason E. Ekert
Impact in
- Small Animals top 5%
- Animal testing and alternatives
- Biomedical Engineering top 10%
- 3D Printing in Biomedical Research
Papers in
-
- 3D Printing in Biomedical Research 9
-
- Animal testing and alternatives 3
- Co-authors
- Alice F. Tarantal (3 shared papers)José R. Pardinas (1 shared paper)Robert A. Perkinson (1 shared paper)Brandy Strake (1 shared paper)Kjell Johnson (1 shared paper)Stephen W. Jarantow (1 shared paper)David C. Colter (1 shared paper)Donald B. Kohn (2 shared papers)
- Journals
- Stem Cell Reports (2 papers)Molecular Therapy (2 papers)Redox Biology (1 paper)BMC Pharmacology and Toxicology (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Jason E. Ekert
16 papers receiving 662 citations
Jason E. Ekert's Hit Papers
Peers
Comparison fields: 5 of 73
- Small Animals 49
- Biomedical Engineering 182
- Oncology 98
- Immunology 75
- Infectious Diseases 61
Countries citing papers authored by Jason E. Ekert
This map shows the geographic impact of Jason E. Ekert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason E. Ekert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason E. Ekert more than expected).
Fields of papers citing papers by Jason E. Ekert
This network shows the impact of papers produced by Jason E. Ekert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason E. Ekert. The network helps show where Jason E. Ekert may publish in the future.
Co-authors
The 25 scholars most cited alongside Jason E. Ekert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 134 | |
| 2 | 2012 | 92 | |
| 3 | 2002 | 76 | |
| 4 | Towards in vitro models for reducing or replacing the use of animals in drug testing Hit paper breakdown → | 2023 | 66 |
| 5 | 2011 | 60 | |
| 6 | 2020 | 58 | |
| 7 | 2001 | 52 | |
| 8 | 2003 | 43 | |
| 9 | 2024 | 42 | |
| 10 | 2023 | 26 | |
| 11 | 2023 | 15 | |
| 12 | 2015 | 8 | |
| 13 | 2018 | 6 | |
| 14 | 2024 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2020 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Jason E. Ekert
Jason E. Ekert is a scholar working on Biomedical Engineering, Small Animals, Biophysics, Emergency Medicine and Genetics, having authored 19 papers that have together received 689 indexed citations. Recurring topics across this work include 3D Printing in Biomedical Research (9 papers), Animal testing and alternatives (3 papers), Virus-based gene therapy research (2 papers), HIV-related health complications and treatments (1 paper), Pluripotent Stem Cells Research (1 paper), Myasthenia Gravis and Thymoma (1 paper), Immune cells in cancer (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Small Animals (49 citations), Biomedical Engineering (182 citations), Oncology (98 citations), Immunology (75 citations) and Infectious Diseases (61 citations). Jason E. Ekert has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Alice F. Tarantal, José R. Pardinas, Robert A. Perkinson, Brandy Strake, Kjell Johnson, Stephen W. Jarantow, David C. Colter, Donald B. Kohn, Robert Martin and Norbert Bischofberger. Their work appears in journals such as Stem Cell Reports, Molecular Therapy, Redox Biology, BMC Pharmacology and Toxicology and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.